Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Cumberbatch

Daren James Cumberbatch, Cheshire GB

Patent application numberDescriptionPublished
20090028943PHARMACEUTICAL COMPOSITIONS - Pharmaceutical compositions comprising AZD2171 or a pharmaceutically acceptable salt thereof, including pharmaceutical compositions comprising AZD2171 or a pharmaceutically acceptable salt and a plastic filler with a high surface area, excluding lactose.01-29-2009

Marie Cumberbatch, Manchester GB

Patent application numberDescriptionPublished
20090253631Anti-Inflammatory Peptides - The present invention relates, inter alia, to a method of ameliorating an inflammatory skin condition. Thus, the present invention provides a peptide that includes the amino acid sequence KMIKP (SEQ ID NO: 20), wherein the peptide includes no more than 70 amino acids and wherein the peptide is capable of inhibiting allergen induced Langerhans cell migration, and wherein the peptide is not that depicted in SEQ ID NO. 19. The present invention also relates to the use of a peptide that includes the amino acid sequence KMIKP (SEQ ID NO: 20), wherein the peptide includes no more than 100 amino acids, and wherein the peptide is capable of inhibiting allergen induced Langerhans cell migration, in the manufacture of a topical medicament for the treatment of an inflammatory skin condition.10-08-2009

Marie Cumberbatch, Alderley Park GB

Patent application numberDescriptionPublished
20090203586METHOD FOR AMELIORATING AN INFLAMMATORY SKIN CONDITION - The present invention relates to the use of thioredoxin in the manufacture of a medicament suitable for application to a skin surface for ameliorating an inflammatory skin condition. The present invention further relates to a method of ameliorating an inflammatory skin condition comprising applying to a skin surface an effective amount of a composition comprising thioredoxin. The invention further relates to a pharmaceutical composition suitable for ameliorating an inflammatory skin condition comprising from 0.0001 to 0.5 w/v thioredoxin.08-13-2009